The timing is the story: Grove competed under a pending positive before the suspension was disclosed publicly, which is exactly the gap that provisional bans are supposed to close quickly. Ipamorelin sits on WADA's prohibited list precisely because it drives growth hormone release without being growth hormone itself—harder to detect, same physiological effect. The ITA catching it mid-season, between a major games and a stage race, signals tighter inter-event sample processing rather than a standalone enforcement failure.